Literature DB >> 9746865

Childhood systemic lupus erythematosus and neonatal lupus syndrome.

C I Sandborg1.   

Abstract

Systemic lupus erythematosus in children can present with a wide spectrum of disease manifestations. Significant organ system involvement appears to be more severe in children than in adults. Central nervous system disease continues to be difficult to diagnose because of the lack of sensitive and specific diagnostic tests. Renal function is the major determinant of long-term prognosis and management in children with lupus. Identification of patients who are most at risk for progression of renal disease and aggressive treatment, including corticosteroids and immunosuppressive agents, are indicated. Genetic susceptibility studies in lupus reveal multiple contributions from HLA and non-HLA genes. Current concepts regarding apoptosis and DNA-protein complexes and autoreactive T-cell help for anti-DNA antibody production suggest novel directions for therapies. New understandings of the pathogenesis of neonatal lupus syndrome and congenital heart block reveals important information about prospective monitoring and management of mothers and fetuses at risk.

Entities:  

Mesh:

Year:  1998        PMID: 9746865     DOI: 10.1097/00002281-199809000-00014

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  2 in total

1.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

2.  Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus.

Authors:  Y J Lee; K S Shin; S W Kang; C K Lee; B Yoo; H S Cha; E M Koh; S J Yoon; J Lee
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.